Affiliation: Karolinska Institute
- Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survivalH Mellin
Division of Clinical Virology, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
Int J Cancer 89:300-4. 2000..These results indicate that HPV status is a significantly favorable prognostic factor in tonsillar cancer and may be used as a marker in order to optimize the treatment of patients with this type of cancer...
- Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancerHanna Mellin
Department of Oncology Pathology, Cancer Centre Karolinska R8 01, Karolinska Institute, Karolinska Hospital, S 171 76 Stockholm, Sweden
Int J Cancer 102:152-8. 2002..In conclusion, HPV-16 is mainly episomal in tonsillar cancer. The viral load showed a wide distribution and the clinical outcome in our study was better when the HPV load was higher...
- Human papillomavirus and DNA ploidy in tonsillar cancer--correlation to prognosisHanna Mellin
Dept of Oncology Pathology, Cancer Center Karolinska, R8 01, Karolinska Institute, Karolinska Hospital, S 171 76 Stockholm, Sweden
Anticancer Res 23:2821-8. 2003..Human papillomavirus (HPV) is frequently observed in tonsillar cancer. Here, tonsillar tumors were examined to see whether DNA content varied depending on HPV status, and influenced clinical outcome...
- Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumorsLiselotte Dahlgren
Department of Oncology Pathology, Karolinska Institute, Karolinska Hospital, Stockholm, Sweden
Int J Cancer 107:244-9. 2003..002). The most common changes, e.g., gain on 3q or 8q, loss on 11q or 13 and loss on chromosome 7q in HPV-negative tumors, did not have any influence on prognosis. However the number of cases in each subgroup was limited...